Trends in interorganizational transactions in personalized medicine development.

Drug Discov Today

Graduate School of Technology Management, Ritsumeikan University, 2-150, Iwakuracho, Ibaraki-shi, Osaka 567-8570, Japan. Electronic address:

Published: February 2019

Personalized medicine is an innovative concept that allows patients with a validated companion diagnosis (CoDx) to receive treatment using the most suitable drug. Currently, a major movement in the pharmaceutical industry involves the integrated use of multiple resources from external sources. To ascertain preferable interorganizational collaborations and their suitable exits, we compared the related transactions in personalized and nonpersonalized cancer drugs. We found that there were significantly more of some alliance deals in personalized medicine, and that market licenses, one of the exits, were well correlated with other alliances only in personalized medicine. Furthermore, four types of collaboration mode were identified, and more active collaborations with external partners were found to lead to more successful outcomes in personalized medicine development.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drudis.2018.09.022DOI Listing

Publication Analysis

Top Keywords

personalized medicine
20
transactions personalized
8
medicine development
8
personalized
6
medicine
5
trends interorganizational
4
interorganizational transactions
4
development personalized
4
medicine innovative
4
innovative concept
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!